suggestive evidence for a susceptibility locus for schizophrenia in chromosome 6q from two indepenWe have investigated whether there is a locus on chromosome 6 that confers an increased susceptibility dent data sets. ᭧ 1997 Academic Press to schizophrenia using a two-stage approach and nonparametric linkage analysis. Allele sharing identical by descent (IBD) and multipoint maximum likelihood INTRODUCTION score (MLS) statistics were employed. Results from two tested data sets, a first data set, or genome scanSchizophrenia affects approximately 1% of the popuning data set, and a second replication data set, show lation (McGue et al., 1983 ) with a severe chronic disorexcess allele sharing for multiple markers in 6q, a der characterized by social withdrawal, illogical thinkchromosomal region not previously reported as linked ing, delusions, and hallucinations and is accompanied to schizophrenia. In our genome scanning data set, ex-in various degrees by social, emotional, and behavioral cess allele sharing was found for markers on 6q13-q26. disruption. Family, twin, and adoption studies have The greatest allele sharing was at interval 6q21-q22.3 shown that genetic factors markedly increase the risk at marker D6S416 (IBD percentage 69; P Å 0.00024). for schizophrenia (Bertelsen, 1985; Gershon et al., The multipoint MLS values were greater than 2.4 in 1988; Gottesman and Bertelsen, 1989; Kendler, 1988). the 11.4-cM interval delimited by D6S301 and D6S303, The risk of the disease in siblings of affected individuwith a maximum value of 3.06 close to D6S278 and of als is about 10 times higher than the population preva-3.05 at D6S454/D6S423. We did not confirm, however, lence (Kendler et al., 1993; Maier et al., 1993) . The (Table 1) . We have mapped these families with maximum of the genome scanning data set, at the in-41 markers spanning chromosome 6. We employed nonterval D6S424-D6S275 (2.35). Our results provide very parametric linkage analyses because of the uncertainty about the mode of inheritance of schizophrenia. Second, we investigated a chromosomal area with nominal P 1 To whom correspondence should be addressed at Unit on Molecular values less than 0.01 (two-point nonparametric linkage Clinical Investigation, Clinical Neurogenetics Branch, 10-4N320, test) with an additional data set (replication data set) NIMH,
Chromosomal Markers
We studied 41 microsatellites markers with average heterozygosity of 0.73 { 0.11 across a region of about 233 cM on chromosome 6. obtained from the National Institute of Mental Health Microsatellite markers were primarily selected from the Généthon (NIMH) Schizophrenia Genetics Initiative (Table 2 ). map (Dib et al., 1996) . Results from four chromosome 6p24-p22 Our results provided supportive evidence for linkage markers (D6S296, D6S470, D6S259, and D6S285) in a subset of 44 of our families were previously reported (Schizophrenia Collaborative of schizophrenia to 6q in two data sets, but did not Linkage Group for Chromosomes 3, 6, and 8, 1997) . Closely spaced confirm a linkage to 6p (Straub et al., 1995) in our markers were used for 6p24-p22 and in a region of chromosome 6q systematic scanning sample.
that showed a P value £ 0.01 in two-point ASP analysis with one of our screening markers (D6S261).
MATERIALS AND METHODS

Laboratory Techniques Genome Scanning Data Set (First Data Set)
All affected sibling pairs with DNA and available biological parents were genotyped. The genotyping of the genome scanning data set was A total of 53 families were studied. Minimal criteria for inclusion performed by radioactive methods as previously described (Gejman et in the study were two participating siblings affected with either al., 1993). Typically, two sets of primers were included in each reacschizophrenia or schizoaffective disorder with chronic psychosis.
tion. Polymerase chain reactions (PCRs) were prepared by a robot Families were recruited mainly by advertisements through an advo-(Biomek 2000, Beckman Instruments). For the study of the replicacacy group (National Alliance for the Mentally Ill) and by clinical tion data set, we have employed fluorescence-based genotyping. collaborators. This study was approved by the NIMH Institutional Genotyping was performed using an ABI Prism 377 DNA sequencer Review Board, and all participants gave written informed consent.
(Perkin-Elmer). DNA amplification conditions of fluorescently laDiagnostic resources included a semistructured diagnostic interview beled primer panels were as recommended by the manufacturers. [Schedule for Affective Disorders and Schizophrenia-Lifetime VerAfter PCR, aliquots of PCR products were pooled into specific groups sion (SADS-L)] (Endicott and Spitzer, 1978) , systematic review of with a Hydra 96 microdispenser (Robbins Scientific). Electrophoretic medical records (at least one medical record per affected individual; data were collected and analyzed using Genescan and Genotyper average number of medical records 2.8), and family history intersoftware (ABI) and automated binning software (Ghosh et al., 1997) . views (Gershon et al., 1988) . Final DSM-III R diagnosis (APA 1987) For both methods, each genotype was read by two independent readbased on all sources of information was performed by the best estiers, blind to diagnosis, and inconsistencies were resolved in the presmate diagnosis method. All families were collected in the United ence of a senior investigator (P.V.G.). States. Thirty-three families were previously described (DeLisi et al., 1987; Gershon et al., 1988 ). An additional 20 families were collected by the same methods. The 53 families contained 81 ASPs considering Genetic Analyses all possible pairs (Table 1) . In this clinical sample the age of onset of schizophrenia, counted as first hospital admission for symptoms Allele frequencies for all markers were estimated from the families genotyped for this study using the program ILINK (Cottingham et of the disease, was 21.6 { 8.1 years. The ethnic composition was (defined as predominant ethnic composition per family) : Caucasian al., 1993; Lathrop and Lalouel, 1984; Schaffer et al., 1994) . Genetic analyses and checks for Mendelian inheritance provided information 77.1%; Slavic 7.0%; African-American 3.5%; and other 12.4%. Of all the possible ASP combinations, the ASP types were schizophrenia-for double or multiple recombinants. Distance between markers was estimated from the Généthon map and by two-point linkage analysis; schizophrenia, 43.7%; schizophrenia-schizoaffective, bipolar type 31.0%; schizophrenia-schizoaffective, depressive type 10.3%; schizo-the order of markers was compatible with those of the Généthon map (Dib et al., 1996) . affective, depressive type-schizoaffective depressive type 4.6%; schizoaffective, bipolar type-schizoaffective, depressive type 3.4%; schizoaffective, bipolar type-schizoaffective, bipolar type 6.9%.
Sibpair Analysis
Allele sharing method. This method scores marker alleles transReplication Data Set (Second Data Set) mitted from each informative parent to a pair of affected sibs as shared or unshared. The proportion of allele sharing is estimated by Sixty-nine families with an affected sib pair with schizophrenia or schizoaffective disorder were obtained from the NIMH Schizophrenia N 1 /m, where m Å N 1 / N 0 . N 1 and N 0 are the total number of shared and unshared alleles IBD, respectively, and m is the total number Genetics Initiative collection. These pedigrees were ascertained at three institutions-Columbia University, Harvard University, and of informative meioses (number of heterozygous parents with IBD status unambiguously determined in the ASPs). The observed distriWashington University (St. Louis). Data collection included a structured interview with the Diagnostic Interview for Genetic Studies bution of shared to unshared alleles IBD is compared to the expected distribution (i.e., N 1 Å N 0 Å m/2), under the null hypothesis of no (Nurnberger et al., 1994) ; family history data were collected by using the Family Instrument for Genetic Studies; and diagnosis was made linkage between marker and disease, using a one-sided x 2 test, both parents are genotyped but may influence sharing when families lack genotypes in one or both parents. decreased power of detection and produce false-negative Maximum likelihood score (MLS). The MLS method (Risch, results (Holmans and Clayton, 1995; Tores et al., 1996) . 1990b) computes a test statistic T, which is analogous to a lod score To determine the potential for these artifacts in our test (i.e., the log 10 of T is the log 10 of the odds in favor of linkage).
sample, we have performed analyses with the subset of The statistic T is the ratio of the likelihood of the observed marker information among ASPs maximized as a function of the three IBD families with both parents available for genotyping (0, 1, or 2) probabilities (Z) to the likelihood of the marker data under (data not shown). Interestingly, these analyses showed the null hypothesis of no linkage (i.e., IBD probabilities set equal to the results obtained with the x 2 sharing method (data In our primary analyses we have considered all the possible ASPs not shown). The highest MLS values were obtained at as independent. However, the significance levels of these results can D6S416 (MLS 3.11) and D6S474 (MLS 3.6), both results be biased at the extremes of the distribution. We corrected for this in two ways. First, we have employed a weighting function that highly suggestive of linkage. The MLS values, as exweights by a factor Å 2/r (r is the total number of affected siblings pected, are reduced when a weighting function is emwithin a sibship) the contribution of each affected pair of siblings ployed (D6S474, MLS 2.6; D6S416, MLS 1.44). (Hodge, 1984) . For this analysis, although the total number of ASPs To use information from all the markers from a chrois used, the statistic is the sum of the weighted contributions. Second, mosomal area together, we performed multipoint ASP for the most significant markers we have computed the empirical P values that give a good approximation to the true significance of the analyses using the MLS method. Multipoint analysis results, although they involve a substantial amount of simulation.
increases the power of detecting linkage and locating a
We thus estimated the empirical P values associated with our twodisease locus, and it allows for exclusion mapping point ASP linkage results by simulating under the null hypothesis (Risch, 1990b (Risch, , 1993 . We observed MLS § 1.0 along an of no linkage marker data among ASPs in 5000 replicates only for the most significant markers.
approximately 45-cM region of 6q (Fig. 1) . Characteristic of complex disease mapping, the exact location of a candidate susceptibility locus could not be defined precisely; RESULTS however, the maximum MLS was obtained at D6S454-D6S423. The MLS values are, as expected, higher when The characteristics of the families employed in the two data sets are given in Tables 1 and 2 . In the first independence of the ASPs is assumed (whole sample: unweighted MLS Å 3.04; weighted MLS Å 1.7). In the stage, we screened all of chromosome 6 using 53 families with a total of 81 ASPs in the genome scanning subset of fully informative families (both parents genotyped), all MLS values in 6q were greater than 0.97. For data set of families, and we analyzed the results with two-point and multipoint nonparametric linkage anal-this subset of families, the highest MLS value was also located at D6S454-D6S423 (unweighted MLS Å 5.4 and yses. The genotyping included 17 markers on 6p and 24 markers on 6q.
weighted MLS Å 3.4). It has been shown that ignoring the dependence To minimize the total number of statistical tests, we used a single affection status model that included indi-among sib pairs may lead to slightly liberal sharing x 2 and MLS statistics, whereas the inclusion of a viduals with schizophrenia or schizoaffective disorder as affected. The results of the two-point analyses for weighting function in the calculations causes the statistics to be too conservative, particularly when parental the genome scanning data set are given in Table 3 . Within the 6p area, no locus had a P õ 0.05. On the marker information is missing (Meunier et al., in press). In multipoint MLS analysis, similar trends have other hand, a cluster of markers over a broad region of (Hodge et al., 1984) . Comparisons for which P õ 0.05 are shown in boldface. All P values in the table are nominal. We also computed the empirical P values for the markers having the highest significance levels for the two-point test: D6S416 empirical P Å 0.0005, D6S474 empirical P Å 0.0045. been shown (Daly and Lander, 1996) . Within the 6p the 6p markers D6S296, D6S260, D6S274, and D6S285
were 05.53, 02.38, 00.90, and 00.70, respectively. area, including the previously reported linked area at 6p24-p22 and the HLA region (Schwab et al., 1995;  We evaluated the 6q region in a replication data set composed of families from the NIMH Schizophrenia Straub et al., 1995) , all MLS values were less than 0.6.
We tested the likelihood of a chromosome 6 schizo-Genetics Initiative with 14 markers from 6q13-q26. Linkage results by the sharing method are given for phrenia susceptibility gene in our genome scanning data set by computing maximum likelihood scores un-each marker (Table 4) . Markers over a region of approximately 21 cM showed P values õ 0.05 with analysis. der a fixed l s (sibling risk ratio attributable to this putative schizophrenia gene, so that Z 0 Å 0.25/l s The strongest evidence was obtained at D6S424 (IBD percentage Å 64, P Å 0.0004), at D6S423 (IBD percentvalue). We used two different fixed values of l s : one for a locus of l s Å 3 and the other for a locus of smaller age Å 63, P Å 0.0009), and at D6S283 (IBD percentage Å 62, P Å 0.0009). When a weighting function was effect l s Å 2. Chromosome 6p was essentially excluded for l s Å 3. However, only a small fraction of 6p could applied (Hodge, 1984) , the results remained positive (all families included: D6S283, IBD percentage Å 62, be excluded for a l s Å 2 (Fig. 1) . The MLS values for FIG. 1. Multipoint MLS scores (MLS expressed as log 10 of the statistic) for chromosome 6 (Risch, 1990b) for the genome scanning data set (first data set). The exclusion maps are plotted for values 0 to 04. P Å 0.0027; and D6S423, IBD percentage Å 62, P Å 40 cM reaching the interval D6S267-D6S408 (Fig. 2) .
The maximum MLS of this data set is at the interval 0.0045). Two-point MLS results (data not shown) were in reasonable agreement with the results obtained with D6S300-D6S283, about 10 cM centromeric to the location of the maximum MLS of the genome scanning data the x 2 sharing method. The highest MLS values were obtained at D6S424 (MLS 2.8, P Å 0.00032) and set. Overall, these results support an overlapping area of linkage in 6q13-q26 in both data sets. D6S423 (MLS 2.64, P Å 0.00047); both results support linkage. The two-point MLS values, as expected, are reduced when a weighting function is employed DISCUSSION (D6S424, MLS 2.07, P Å 0.0018; D6S423, MLS 1.78, P Å 0.0037; and D6S283, MLS 1.96, P Å 0.0024).
The results of this study provide suggestive evidence for linkage of schizophrenia to chromosome 6q in two Multipoint MLS values §1.0 started at the interval D6S455-D6S275, approximately 10 cM centromeric to independent data sets. The appropriate P values for declaring a linkage to be significant are not universally equivalent scores in the first data set, and encompass 
FIG. 2.
Multipoint MLS scores (MLS expressed as log 10 of the statistic) map for chromosome region 6q13-q21 for the replication data set (Risch, 1990b) . Unweighted MLS values for the second data set are plotted in the background. agreed upon. Lander and Kruglyak (1995) propose that values were greater than 2.4 in the 11.4-cM interval delimited by D6S301 and D6S303, with a maximum a nominal P value of 2.2 1 10 05 is needed to declare linkage in a whole genome scan, using ASP analysis, value of 3.06 close to D6S278 and of 3.05 at D6S454/ D6S423. In our replication data set ú1 multipoint MLS and slightly less significant P values can be called suggestive linkage (2.2 1 10 05 õ P õ 7.4 1 10
04
). Our values start approximately 10 cM centromeric to those in the genome scanning data set. The maximum MLS results with the genome scanning data set fulfill the ''suggestive'' criteria when either independence among also occurs at a slightly more centromeric location than in the genome scanning data set. We would like to emASPs is assumed for multipoint analysis or when empirical P values are calculated for the x 2 sharing test phasize that in both data sets the area with MLS values §1 greatly overlap. In contrast to our screening data (D6S416) ( Table 3 ). Significance levels were lower when a weighting function that accounts for noninde-set, the significance of linkage of our replication data set for the 6q13-q26 area does not require adjustment pendence among ASPs was used (Hodge, 1984) . However, the inclusion of a weighting function for these for multiple testing with hundreds of markers covering the whole genome. Therefore our results provide evicalculations might cause the statistics to be too conservative and lose sensitivity, particularly when parental dence for linkage of a schizophrenia susceptibility locus located on chromosome 6q at a significance level of P marker information is missing (Meunier et al., in press ). In our analyses, the use of a weighting function õ 0.001.
There are some phenotypic and ethnic differences yielded larger P values than the computing of empirical P values (see Table 3 ). Notwithstanding, we would like between the two data sets. The genome scanning data set includes, in addition to subjects with schizophrenia to emphasize that these P values are guidelines only (Witte et al., 1996) and that our conclusion from the and schizoaffective, depressive-type disorder, individuals with schizoaffective disorder of bipolar type. In fact, initial data set is that this region of 6q may contain a schizophrenia susceptibility gene and needs to be stud-of all ASP combinations, in 41.3% of the cases there is a subject with schizoaffective, bipolar-type disorder. ied in other data sets with markers in the 6q13-q21 area.
Conversely, in the replication data set, families including siblings with this diagnosis were excluded from the The replication data set also showed excess allele sharing on chromosome region 6q13-q26 markers, pro-initial collection. There are also differences in the ethnic make-up of these two samples, particularly regardviding additional evidence for a susceptibility locus in 6q (Table 4 ). The highest sharing for this data set was ing the proportion of families with predominant African-American ancestry: In the genome scanning data at D6S424 (unweighted analysis, IBD percentage 64, P Å 0.0004; weighted analysis IBD percentage: 63, P set, only 3.5% of the families were classified as AfricanAmerican, while in the replication data set 35% of the Å 0.0023). Positive multipoint MLS scores show reasonable overlapping between the two data sets (Fig. 2) . families were of African-American ancestry. Interestingly, in spite of these differences, an overlapping area In our genome scanning data set, the multipoint MLS of excess allele sharing and of positive two-point and
